Tag Archives: Barrington Miller

Chris Driessen on Building “THE” House of Brands in Cannabis | #HashtagFinance

CSE’s Barrington Miller is joined by Chris Driessen, CEO of SLANG Worldwide Inc. (CSE:SLNG) to discuss how he is applying his skill set in his recently appointed role as CEO and what he thinks it means to build “THE” ‘House of Brands’ in the cannabis industry.

Here’s an overview of what Barrington and Chris cover in this edition of the #HashtagFinance podcast:

0:35 – Introducing Chris Driessen
3:55 – How to compete in the Colorado market
5:41 – Building ‘THE’ House of Brands
7:35 – Upcoming milestones for 2021
9:20 – The foundation of SLANG’s culture
12:30 – Popular products during COVID
15:35 – Discussing Colorado – an early hot spot for the industry
17:35 – Why North American footprint is critical
19:00 – What are the company’s KPIs?
22:50 – The importance of making good on promises

About SLANG Worldwide Inc.
SLANG Worldwide Inc. is a global leader in the cannabis CPG sector with a diversified portfolio of popular brands distributed across the United States. The Company specializes in acquiring and developing market-proven regional brands as well as launching innovative new brands to seize global market opportunities. SLANG is listed on the Canadian Securities Exchange under the ticker symbol SLNG and on the OTCQB under the symbol SLGWF.

Learn more about SLANG Worldwide at https://thecse.com/en/listings/life-sciences/slang-worldwide-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Bob Groesbeck on the Vegas Retail Rollercoaster of 2020 | #HashtagFinance

CSE’s Barrington Miller chats with Bob Groesbeck, Co-CEO of Planet 13 Holdings Inc. (CSE:PLTH) about his company’s challenges – and newfound opportunities – serving customers through their Vegas SuperStore during the pandemic:

0:35 – Introducing Planet 13 holdings – an entertainment company
1:35 – Life since MJBiz in Vegas
4:33 – Having the team to make the transition to delivery possible
7:03 – The Planet 13 product offerings – expansion of the house brand
10:24 – Current tourism trends
12:58 – What the company plans to do with its recently raised funds
14:49 – Post-COVID plans
16:44 – Origin of the Planet 13 name

Planet 13 is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas – the entertainment capital of the world. Planet 13’s mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13’s shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Related links
www.planet13holdings.com
https://thecse.com/en/listings/life-sciences/planet-13-holdings-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Michael Frank on the Race to Fight Infectious Diseases | #HashtagFinance

CSE’s Barrington Miller chats with Michael Frank, CEO of Revive Therapeutics Ltd. (CSE:RVV) about his company’s ambitions to enter Phase 3 clinical trial protocol to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19.

With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury
from organ transplantation.

Related links
https://revivethera.com/
https://thecse.com/en/listings/life-sciences/revive-therapeutics-ltd

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Jonathan Buick on Developing a Technical Knockout in Idaho | #HashtagFinance

CSE’s Barrington Miller chats with Jonathan Buick, CEO of Idaho Champion Gold Mines Canada Inc. (CSE:ITKO) about his company’s recently closed $8.1 million bought deal financing and the plans for its two fully funded 2020 exploration programs at its Baner and Champagne Gold Projects located in Idaho, USA.

Idaho Champion is a discovery-focused gold exploration company that is committed to advancing its 100% owned highly prospective mineral properties located in Idaho, United States. The Company’s shares trade on the CSE under the trading symbol “ITKO”. Idaho Champion is vested in Idaho with the Baner Project in Idaho County, the Champagne Project located in Butte County near Arco, and four cobalt properties in Lemhi County in the Idaho Cobalt Belt. Idaho Champion strives to be a responsible environmental steward, stakeholder and a contributing citizen to the local communities where it operates. Idaho Champion takes its social license seriously, employing local community members and service providers at its operations whenever possible.

Related links
https://idahochamp.com/
https://thecse.com/en/listings/mining/idaho-champion-gold-mines-canada-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Dr. Ahmad Doroudian on the Potential of a COVID-19 Treatment | #HashtagFinance

Dr. Ahmad Doroudian on the Potential of a COVID-19 Treatment, Not a Cure | #HashtagFinance

The CSE’s Barrington Miller chats with Dr. Ahmad Doroudian, CEO of BetterLife Pharma Inc. (CSE:BETR), about BetterLife’s ambitions to advance on the AP-003 clinical trial programs of Altum Pharmaceuticals Inc., which includes a therapeutic pipeline consisting of three products, including AP-003, a patent-pending interferon a2b (IFNa2b) inhalation formulation. Recent studies in China and the UK have provided data that suggest the therapeutic efficacy of interferon-based treatments for COVID-19.

Here’s an overview of what’s covered in this edition of the #HashtagFinance podcast:

3:47 – What BetterLife is doing about COVID-19.

7:01 – How early their product can be used, and if it can be used for prevention.

9:32 – What BetterLife was working on before the COVID-19 pandemic.

11:32 – The differentiators between BetterLife and other companies developing COVID-19 treatments.

15:38 – Taking the treatment approach, instead of the cure approach, to COVID-19, similar to HIV.

19:58 – Phase II clinical trials, and what that means for an investor.

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, BLife Therapeutics Inc., BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Related links:

Home

https://thecse.com/en/listings/life-sciences/betterlife-pharma-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Brad Moore on Leveraging Blockchain to Improve Outcomes for Medical Cannabis Patients | #HashtagFinance

CSE’s Barrington Miller chats with Brad Moore, CEO of Global Cannabis Applications Corp. (CSE:APP) about his company’s ambitions as a technology company that strives to improve medical cannabis patients’ outcomes through the gathering and analysis of deep data.

Here’s an overview of what Barrington and Brad cover in this edition of the #HashtagFinance podcast:

1.10 – Virtual work is nothing new for Brad and his international team.
3:35 – GCAC’s Israeli technology connection.
6:01 – How Brad has applied his military mindset into the cannabis/tech industries.
9:53 – The impact of the early 2018 cannabis “craze” on the company.
13:54 – Defining 2020 as the year of the (delayed) balance sheet.
15:46 – The application of blockchain on their business model.
18:20 – Building data points during COVID.
19:35 – The differentiator.
23:53 – The power of data to improve patient incomes.
28:47 – What a potential exit path looks like for the company.

Current approval processes for medical treatments generally start with a formulation of elements. The objective of any clinical study is to ensure efficacy, and safety, within a fixed sampling size. However as cannabis is a plant, and each plant is unique, the challenges have been in ensuring that each gram tested would provide a consistent result. In response to these challenges, GCAC has developed a patent-pending data model called, Seed to Seed.

GCAC’s approach is to measure an individual’s unique treatment experience on a per dosage basis. By digitally measuring both the biometric & anecdotal feedback and comparing that to others using the same or similar products on a large scale, GCAC can provide an averaged efficacy rating for the treatment used. This is accomplished through a proprietary system of mobile applications, heart monitoring biometrics, Artificial Intelligence and machine learning. When integrated with blockchain seed to sale solutions, GCAC technology will be able to recommend “how to treat ailment X with product Y at a given point in time under a set of circumstances”. By securing this information on an EU GDPR complaint blockchain, their data outputs are comparable to results generated by a regulatory approval process.

Related links:
https://thecse.com/en/listings/technology/global-cannabis-applications-corp

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Paul Rosen on the One Non-Negotiable for Success in Cannabis | #HashtagFinance

CSE’s Barrington Miller chats with Paul Rosen, CEO of 1933 Industries Inc. (CSE:TGIF) about his recent appointment as Interim CEO of the company and his operating philosophy moving forward in the face of COVID-19. Paul also shares his personal journey as an early leader in the cannabis industry and makes note of the many changes he’s observed in the C-suite among his cannabis sector peer group.

Here’s an overview of what Barrington and Paul cover in this edition of the #HashtagFinance podcast:

2:00 – Paul’s early beginnings in the Cannabis industry in the late 80’s as a constitutional lawyer.
3:58 – Hortican Inc.’s pre-MMPR history and evolution with PharmaCan Capital Corp./The Chronos Group.
6:57 – His transition into a management role at 1933 Industries.
7:55 – How Cannabis 2.0 has impacted C-suites in the industry.
11:58 – Highlighting traits of the early-stage Cannabis entrepreneurs.
13:28 – The unique challenges of running a public cannabis company.
17:16 – The imperative of running a clean balance sheet in today’s COVID-19 environment.
20:14 – Las Vegas’ cannabis prospects in light of the severe downturn in tourism.
25:25 – Paul’s view on how the global pandemic will hasten tax generation from cannabis and social justice.
29:35 – Why preparing for domestic (US) demand is still the biggest opportunity in cannabis.
31:57 – The shift to prioritizing profitability first.

1933 Industries is a vertically-integrated, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats.

Related Links
https://1933industries.com/
https://thecse.com/en/listings/diversified-industries/1933-industries-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Daniel Safayeni on the OCC’s Fight to Save Curbside Cannabis | #HashtagFinance Special Edition

CSE’s Barrington Miller is joined by Daniel Safayeni, Director of Policy at the Ontario Chamber of Commerce to discuss the Provincial Government’s decision to end curbside pick-up and delivery of legally purchased cannabis products. Brought-in as a temporary pandemic measure, the decision to not extend (or make permanent) this policy poses risks to public safety, economic growth and employment opportunities. At this current time there is no other industry that has this measure being rescinded. Daniel also act’s as the co-chair Ontario Cannabis Policy Council (OCPC).

Learn more and connect with the OCC to show your support here: https://occ.ca/mediareleases/ontario-…

and/or contact your local MPP (Member of Provincial Parliament)

AND share this video to support the cause!

🔴 Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Guy Goulet on Green Resource Management in Peru | #HashtagFinance

On this episode of #HashtagFinance, CSE’s Barrington Miller talks with Guy Goulet, CEO of Cerro de Pasco Resources Inc. (CSE:CDPR) and how the company is focused on applying the latest technology in the production of commodity metals through the treatment and reprocessing of all material resources, dumps, tailings, mining waste and more in order to secure long-term economic prosperity in Peru.

Here’s an overview of what they cover in this podcast:

2:03 – Mineral rights by the numbers.
4:41 – Prospects for the mining sector, gold and silver specifically.
6:39 – Guy’s last visit to Cerro de Pasco.
8:20 – How raising $50M is easier than raising “small” money.
10:46 – Cerro de Pasco’s history including the largest copper stock in the world.
11:34 – Why processing tailings is easier than mining rock.
14:06 – How Guy utilizes his background as a geological engineer in the capital markets.
16:58 – The Cerro de Pasco puzzle and how it comes together.
17:42 – Why he needs to remind stakeholders that its a remediation project, not a mining project.
21:31 – The latest development including their merger with Volcan Compañia Minera S.A.A.

Related links:
https://pascoresources.com/
https://thecse.com/en/listings/mining/cerro-de-pasco-resources-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Stephen Stewart on Hunting for Kirkland Lake Gold | #HashtagFinance

On this episode of #HashtagFinance, CSE’s Barrington Miller was joined by Stephen Stewart, Director of Mistango River Resources Inc. (CSE:MIS) to discuss the why they are hunting for Kirkland Lake gold. He also addresses the dramatic evolution of the company over the past 12 months and why he’s excited about the prospects for the company’s assets in the Kirkland Lake camp.

In this discussion, Stephen Stewart shares how the company is focused on two flagship assets located on the Abitibi Greenstone Belt (3:39), the intertwined history of Kirkland Lake and the mysterious Sir Harry Oakes (6:31), and what drew mining finance legend Eric Sprott to invest in the company. Listen until the end to hear Stephen’s views on the risk and reward factors in mineral exploration, how the “gold bug” narrative is impacting their business, and details concerning this summer’s exploration program.

Related links www.mistango.com thecse.com/en/listings/mining/mistango-river-resources-inc

Subscribe: Apple Podcasts / Spotify / SoundCloud / Stitcher / Google Podcasts / RSS